Drug Type Therapeutic vaccine |
Synonyms- |
Target |
Action agonists, modulators |
Mechanism 4-1BB agonists(Tumor necrosis factor receptor superfamily member 9 agonists), E2 modulators(Hepatitis C virus E2 glycoprotein modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | Austria | 08 Apr 2022 |